Valuation: Harbin Pharmaceutical Group Co., Ltd.

Market Cap 13.35B 2B 1.8B 1.66B 1.5B 2.81B 190B 2.85B 19.89B 7.9B 99.65B 7.51B 7.35B 316B P/E 2026 *
22.1x
P/E 2027 * 18.9x
Enterprise Value 13.35B 2B 1.8B 1.66B 1.5B 2.81B 190B 2.85B 19.89B 7.9B 99.65B 7.51B 7.35B 316B EV / Sales 2026 *
0.81x
EV / Sales 2027 * 0.79x
Free-Float
48.71%
Yield 2026 *
-
Yield 2027 * -
1 day-3.64%
1 week-9.56%
Current month-28.38%
1 month-34.89%
3 months-6.03%
6 months+44.41%
Current year+53.62%
1 week 5.26
Extreme 5.26
5.99
1 month 5.26
Extreme 5.26
7.87
Current year 2.84
Extreme 2.84
9.86
1 year 2.84
Extreme 2.84
9.86
3 years 2.41
Extreme 2.41
9.86
5 years 2.41
Extreme 2.41
9.86
10 years 2.38
Extreme 2.38
9.86
Manager TitleAgeSince
Chief Executive Officer 64 27/12/2023
Director of Finance/CFO 54 24/12/2004
Investor Relations Contact 45 27/04/2022
Director TitleAgeSince
Director/Board Member 60 08/01/2021
Chairman 56 27/12/2023
Director/Board Member 46 27/06/2022
Date Insider Type Main position Quantity % Market Cap. Importance
01/07/24 Sell 36,000 0.0014%
01/07/24 Sell 27,000 0.0011%
01/07/24 Sell

Chief Financial Officer

90,000 0.0036%
Change 5-day change 1-year change 3-year change Capi.($)
-3.64%-9.56%+44.41%+48.04% 2B
+0.22%-0.14%+55.12%+128.82% 1,143B
+0.91%+3.61%+41.21%+84.57% 647B
-0.12%-0.93%+25.59%+106.14% 506B
-1.07%+0.87%+51.44%+63.86% 384B
+0.86%-4.37%+61.16%+37.93% 350B
+0.46%+2.36%+31.36%+53.47% 293B
-0.53%+1.24%+2.93%+24.98% 265B
+0.75%+2.05%+53.85%+71.25% 242B
+0.25%+1.64%+32.05%+107.62% 197B
Average -0.43%-0.36%+39.91%+72.67% 402.95B
Weighted average by Cap. -0.13%+0.70%+42.98%+87.93%

Financials

2026 *2027 *
Net sales 16.4B 2.46B 2.21B 2.04B 1.85B 3.45B 234B 3.5B 24.44B 9.71B 122B 9.23B 9.04B 388B 16.94B 2.54B 2.28B 2.1B 1.91B 3.57B 241B 3.61B 25.24B 10.02B 126B 9.53B 9.33B 401B
Net income 607M 90.98M 81.65M 75.4M 68.37M 128M 8.64B 129M 904M 359M 4.53B 342M 334M 14.36B 699M 105M 94.06M 86.85M 78.76M 147M 9.95B 149M 1.04B 414M 5.22B 393M 385M 16.55B
Net Debt - -
Projected Income Statement - Annual - Harbin Pharmaceutical Group Co., Ltd.
Logo Harbin Pharmaceutical Group Co., Ltd.
Harbin Pharmaceutical Group Co Ltd is a China-based company mainly engaged in the research and development, manufacturing, wholesale and retail of pharmaceutical. The Company is mainly engaged in two businesses. The pharmaceutical industry business is mainly engaged in the research, development and manufacturing of chemical raw materials, chemical preparations, biological preparations, traditional Chinese medicine and health care products. The pharmaceutical commercial business is mainly engaged in pharmaceutical commercial wholesale business and pharmaceutical commercial retail business. The Company's products mainly include zinc gluconate oral solution, calcium iron zinc oral solution, compound calcium gluconate oral solution, amoxicillin capsules and Shuanghuanglian oral solution. The Company's products are mainly used in digestive, respiratory, anti-infectious, cardiovascular and cerebrovascular and anti-tumor treatment fields.
Employees
10,039
Date Price Change Volume
27/10/26 CN¥5.300 -3.64% 142,892,913
26/10/26 CN¥5.500 -1.08% 150,256,611
23/10/26 CN¥5.560 0.00% 212,620,419
22/10/26 CN¥5.560 -6.87% 207,590,754
21/10/26 CN¥5.970 +1.88% 241,378,399
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
5.300CNY
Average target price
9.160CNY
Spread / Average Target
+72.83%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Harbin Pharmaceutical Group Co., Ltd.
  1. Stock Market
  2. Stocks
  3. 600664 Stock